The net balance of matrix metalloproteinases (MMP) and tissue inhibitor of metalloproteinases (TIMP) system has been known to be a key factor in tumor cell invasion. In the present study, we investigated the molecular mechanisms of anti-invasive and antimigrative activity of transforming growth factor (TGF)-B1 on HT1080 human fibrosarcoma cells. In in vitro Matrigel invasion and Transwell migration assays, TGF-B1 dose-dependently inhibited the invasion and migration of HT1080 cells, respectively. Gelatin zymography, Western blot, and real-time PCR analysis showed that TGF-B1 enhanced the expression and secretion of MMP-2, TIMP-1, and, to a lesser degree, MMP-9 but not membrane type 1-MMP and TIMP-2. The addition of recombinant TIMP-1 protein reduced the Matrigel invasion and Transwell migration of HT1080 cells, similar to TGF-B1. Because augmentation of TIMP-1 might be the major factor for the anti-invasive and antimigrative activity of TGF-B1, we investigated possible molecular mechanisms responsible for the expression of TIMP-1 induced by TGF-B1. Treatment of HT1080 cells with TGF-B1 rapidly phosphorylated three mitogen-activated protein kinases [MAPK; extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun NH 2 -terminal kinase] and Akt. Among these kinases, the inhibition of only ERK1/2 pathway by PD98059, a specific inhibitor of MAPK/ERK kinase(MEK)-1, and transfection of dominant-negative MEK 1 effectively blocked the TIMP-1 induction by TGF-B1. Mithramycin, a specific inhibitor of Sp1 transcription factor, but not curcumin, an inhibitor of activator protein-1, and transfection of Sp1 small interfering RNA significantly inhibited the TGF-B1-induced expression of TIMP-1. In addition, electrophoretic mobility shift assay showed that TGF-B1 up-regulated Sp1 DNA-binding activity, and PD98059 and mithramycin effectively inhibited these events. Finally, pretreatment of HT1080 cells with PD98059 and mithramycin, but not curcumin, restored the invasive activity of these cells. Taken together, these data suggest that TGF-B1 modulates the net balance of the MMPs/TIMPs the systems in HT1080 cells for antiinvasion and antimigration by augmenting TIMP-1 through ERK1/2 pathway and Sp1 transcription factor.
Introduction
Tumor cell invasion is a multistep process, involving several interactions between tumor cells and extracellular matrix (ECM), particularly a directed proteolysis of ECM, such as basement membranes required for intravasation and extravasation of tumor cells (1) . Proteolytic degradation of ECM components involves several proteases, such as matrix metalloproteinases (MMP), plasminogen activators, and serine proteases secreted by invading tumor cells (2) (3) (4) (5) . Among the ECM-degrading proteases, however, much attention have been focused on the MMP family, especially MMP-2 and MMP-9, and many evidences have shown that elevated levels of MMP-2 and MMP-9 are well correlated with an invasive phenotype of cancer cells (6) . The extracellular activities of these enzymes are inhibited, when they are complexed with endogenous inhibitors, such as tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. Consequently, an imbalance between MMP and TIMP activities results in an excessive ECM degradation necessary for tumor invasion and metastasis (7, 8) .
TIMPs are multifunctional proteins that can inhibit the catalytic activity of MMPs, thus maintaining ECM homeostasis (9) . Besides acting as proteinase inhibitors, TIMPs also modulate cell growth, apoptosis, and angiogenesis (9) . Currently, four members of the TIMP family have been characterized: TIMP-1, TIMP-2, TIMP-3, and TIMP-4 (10, 11) . Among these, TIMP-1 is a glycosylated protein with molecular mass ranging from 28.5 to 34 kDa, depending on the degree of glycosylation, and is secreted in a soluble form by different cell types and forms a 1:1 complex with MMP-9 (9) . Tumor invasion and metastasis are negatively regulated by TIMP-1 in different types of tumor cell lines (12) (13) (14) (15) (16) , and down-regulation of TIMP-1 expression or mutated TIMP-1 is associated with increased invasiveness (17, 18) . Recent transgenic studies also showed that endogenous overexpression or suppression of TIMP-1 inhibited or enhanced the tumor growth in several cell types, respectively (19) (20) (21) . In addition, TIMP-1 has been shown to exert an antiangiogenic activity both in vitro and in vivo (22, 23) . TIMP-1 promoter contains several 12-O -tetradecanoylphorbol-13-acetateresponsive elements, such as activator protein-1 (AP-1), Sp1, and Ets sites, and functional interaction of these transcription factors has been shown to induce synergistic transcriptional activation of the TIMP-1 promoter. Consequently, contrary to TIMP-2, TIMP-1 expression is up-regulated by several factors, including phorbol esters, interleukin-6, transforming growth factor (TGF)-h1, epidermal growth factor, oncostatin M, or erythropoietin (9, 24, 25) .
TGF-h, 25-kDa homodimeric protein with autocrine and paracrine activities, is a multifunctional protein that has been implicated in various physiologic and pathologic conditions, including cell cycle control, carcinogenesis in human skin, and invasion and metastasis of carcinoma cells (26) . In tumor progression, TGF-h1 has been shown to have dual function, either decreasing or promoting cancer invasion, depending on the type and the progression stage of tumor (27, 28) . Consistent with proinvasive or anti-invasive roles in cancer progression, TGF-h1 stimulates tumor invasion by up-regulating integrin, MMP-2, MMP-9, and urokinasetype plasminogen activator expression (29) (30) (31) (32) (33) while suppresses it by down-regulating plasminogen activator systems, MMPs, and plasmin-dependent ECM degradation through stimulating the expression of TIMP-1 and plasminogen activator inhibitor-1 (34) (35) (36) (37) .
TGF-h1 signaling is initiated via binding of ligand to its serine/threonine kinase receptor type II and then type I on the cell surface (38) . On activation, the type I and II receptors interact to form hetero-oligomers, which then activate receptor-associated Smads, Smad2 and Smad3. The receptorassociated Smads then bind to Smad4, translocate to the nucleus, and ultimately regulate transcription and expression of target genes. Therefore, Smad proteins are the best known intracellular substrates for signal transmitter of TGF-h1 receptor activation (38) . In addition to the Smad-mediated signaling, TGF-h1 also can signal through mitogen-activated protein kinase (MAPK) pathways, including extracellular signal-regulated kinase 1/2 (ERK 1/2) and p38 (39) (40) (41) . Several studies have shown that MAPK pathways are involved in the TGF-h1-mediated modulation of ECMdegrading proteases and their inhibitors in the process of cellular invasion (34, (42) (43) (44) . However, there is little information available about signaling mechanisms of TGFh1-mediated TIMP-1 expression and anti-invasion of tumor cells.
In the present study, we investigated the role of TGF-h1 in the regulation of MMPs and TIMPs expression in HT1080, a cellular model of invasive fibrosarcoma cells, and observed that treatment of HT1080 cells with TGF-h1 significantly upregulated TIMP-1 expression and blocked invasion and migration of the cells and that ERK1/2 and Sp1 signaling pathways were crucially involved in these events.
Results

TGF-b1 Inhibited the Invasion and Migration of HT1080 Cells In vitro
First, we examined the effect of TGF-h1 on invasiveness of HT1080 cells using Matrigel invasion assay system. As shown in Fig. 1A , invasion of HT1080 cells was significant and was reduced dose-dependently by treatment with TGF-h1. Next, the effects of TGF-h1 on the migration of HT1080 cells were determined by Transwell migration assay. In line with the results from the above invasion assays, TGF-h1 also inhibited the migration of HT1080 cells in a dose-dependent manner (Fig. 1B) . No distinctive cellular morphologic changes, which are typically associated with apoptosis, such as cell detachment, rounding, or chromosomal fragmentation, were detected under the experimental condition (data not shown). In addition, significant cytotoxic effect was not detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays in the serum-free medium following up to 100 ng/mL TGF-h1 treatment for 12 and 24 hours ( Supplementary Fig. S1 ), indicating that the anti-invasive activity of TGF-h1 was not due to cytotoxic effect of this cytokine.
Augmentation of TIMP-1 Might Be Responsible for the Anti-Invasive and Antimigrative Activity of TGF-b1 in
HT1080 Cells
Tumor cell invasiveness is strongly associated with the balance between ECM-degrading proteases and their inhibitors, especially MMPs and TIMPs. Therefore, to investigate the effects of TGF-h1 on MMP-2, MMP-9, membrane type 1-MMP (MT1-MMP), TIMP-1, and TIMP-2 induction in HT1080 cells, we measured the expression of these molecules in the conditioned medium or cell lysates by using gelatin zymography analysis and Western blotting. As shown in Fig. 2A and B, treatment of HT1080 cells with TGF-h1 significantly increased the secretion of MMP-2 and TIMP-1, but not MT1-MMP and TIMP-2. TGF-h1 also increased the secretion of MMP-9 but to a lesser degree. Because TGF-h1 modulated the secretion of MMP-2 and TIMP-1 significantly, we further investigated the effect of TGF-h1 on the mRNA expression of these molecules by using quantitative real-time PCR method. As shown in Fig. 2C , TGF-h1 significantly augmented MMP-2 and TIMP-1 mRNA levels in HT1080 cells. Enhanced MMP-2 and TIMP-1 mRNA peaked at 3 and 6 hours, respectively, and declined thereafter.
Because TGF-h1 significantly suppressed the invasion and migration of HT1080 cells, we wondered whether TIMP-1 secretion by TGF-h1 might be critically involved in the inhibition. Therefore, we did Matrigel invasion and Transwell migration assays in the presence or absence of recombinant TIMP-1 and found that TIMP-1 dose-dependently suppressed the invasion and migration of HT1080 cells ( Fig. 2D and E) . However, the addition of TIMP-1 up to 100 ng/mL did not completely inhibit invasion ( Supplementary Fig. S2 ), indicating that TIMP-1 is not the only invasion suppressor in this system.
The above data indicate that TGF-h1 regulates the expression of MMP-2 and TIMP-1 at the transcriptional level and that augmentation of TIMP-1 might be a key event in modulating the balance of MMPs and TIMPs expression against invasion and migration of HT1080 cells. To further confirm that TIMP-1 was the direct mediator of the effects of TGF-h1 on the inhibition of invasion, endogenous expression of TIMP-1 genes in HT1080 cells was silenced by TIMP-1 small interfering RNA (siRNA), and efficient and specific knockdown was observed by Western blot analysis of cell lysates (Fig. 2F) . Transfection of HT1080 cells with TIMP-1 siRNA reduced TGF-h1-mediated inhibition of invasion compared with control siRNA-transfected cells, whereas TIMP-1 siRNA transfection alone slightly up-regulated the invasion of these cells (Fig. 2G) . These results indicate that TIMP-1 is the critical invasion and migration suppressor in HT1080 cells, at least in part.
TGF-b1 Induced Expression of MMP-2 and TIMP-1 through p38 and c-Jun NH 2 -terminal kinase and ERK1/2 Signaling Pathway, Respectively
To elucidate signaling mechanism possibly involved in antiinvasive action of TGF-h1, we next examined whether TGF-h1 influenced MAPKs and Akt signaling pathways in HT1080 cells. As shown in Fig. 3A , treatment of the cells with TGF-h1 strongly up-regulated ERK1/2 and Akt phosphorylation at 15 minutes, lasting up to 180 minutes. TGF-h1 also increased p38 and c-Jun NH 2 -terminal kinase (JNK) phosphorylation, but the effect was weak compared with ERK1/2 and Akt phosphorylation. To further ascertain the involvement of the activation of these kinases in the expression of MMPs and TIMPs, the cells were treated with TGF-h1 in the presence or absence of highly specific inhibitors of MAPK/ERK kinase (MEK)-1 (PD98059), p38 (SB202190), JNK (SP600125), and phosphatidylinositol-3 kinase (PI3K; LY294002). Gelatin zymography, Western blot, and real-time PCR analyses clearly showed that pretreatment of the cells with SB202190 and SP600125, but not PD98059 and LY294002, reduced the increase of MMP-2 induced by TGF-h1, whereas only PD98059 significantly blocked the increase of TIMP-1 by TGF-h1 ( Fig. 3B-D ). Because the above data strongly implicated the involvement of ERK1/2 signaling pathway in TGF-h1-induced TIMP-1 expression, we further investigated the role of ERK1/2 pathway in TGF-h1-stimulated TIMP-1 expression by using dominantnegative (DN) mutants of MAPKs. Thus, we transiently transfected DN mutant plasmids of MEK-1 (the immediate upstream kinase of ERK1/2) and retroviruses for DN form of p38 and JNK into HT1080 cells for 24 hours. After another 24 hours of incubation with TGF-h1 (10 ng/mL) in serum-free medium, we measured the TIMP-1 in the conditioned medium by using gelatin zymography and Western blot analyses. Consistent with the results obtained with the pharmacologic inhibitors, DN-MEK-1 abrogated TGF-h1-induced TIMP-1 expression (Fig. 3E) . On the other hand, transduction of DNp38 and DN-JNK retroviruses significantly suppressed MMP-2 but not TIMP-1 expression by TGF-h1 (Fig. 3F) . These results suggest that ERK1/2 pathway is involved in the regulation of TGF-h1-induced TIMP-1 expression, whereas p38 and JNK pathway is involved in the regulation of MMP-2 expression in HT1080 cells, indicating that TGF-h1 regulates the expression of MMP-2 and TIMP-1 in HT1080 cells through different mechanisms.
TGF-b1-Induced Sp1 Activation Was Involved in TIMP-1 Expression
Several transcriptional factors, including AP-1, Sp1, and 12-O-tetradecanoylphorbol-13-acetate -responsive element, regulate the expressions of TIMP-1 (45, 46) . Therefore, to identify the possible transcription factor involved in TGF-h1-induced TIMP-1 expression, we tested the effect of curcumin and mithramycin, an inhibitor of AP-1 and Sp1, respectively, on the event. As shown in Fig. 4A , pretreatment of the cells with mithramycin, but not curcumin, significantly reduced the secretion of TIMP-1 induced by TGF-h1. Mithramycin also inhibited the induction of TIMP-1 mRNA by TGF-h1 (Fig. 4B) . Furthermore, transfection of Sp1 siRNA significantly reduced the both Sp1 expression and TIMP-1 secretion induced by TGF-h1 as well as basal levels (Fig. 4C) . Next, we investigated the involvement of Sp1 DNA-binding activity in the TIMP-1 expression. Because TGF-h1-mediated TIMP-1 expression was blocked by ERK1/2 inhibition, as shown above, it is likely that the inhibitory effect of PD98059 on TGF-h1-induced TIMP-1 expression might have been mediated, at least in part, through down-regulation of Sp1 DNA-binding activity. To examine this possibility, we did electrophoretic mobility shift assay and found that TGF-h1 strongly increased Sp1 DNA-binding activities and that pretreatment of HT1080 cells with PD98059 and mithramycin effectively inhibited the TGFh1-induced Sp1 DNA-binding activities in a dose-dependent manner (Fig. 5A) . Specificity of the Sp1 band was confirmed by detecting supershift band, when the nuclear proteins were preincubated with Sp1 antibodies (Fig. 5A) . TGF-h1 also induced the AP-1 DNA-binding activity and dose-dependently blocked the event by pretreatment with PD98059 and curcumin (Fig. 5B) . These results together strongly suggest that TGF-h1-mediated TIMP-1 expression in HT1080 cells is regulated dominantly by Sp1 transcriptional activity, which is mediated by ERK1/2. ERK1/2 Pathway and Sp1 Transcription Factor Were Involved in TGF-b1-Induced Anti-Invasion and Antimigration of HT1080 Cells
As shown above, because ERK1/2 and Sp1 signaling pathways were critical for induction of TIMP-1 in HT1080 cells by TGF-h1, we next examined whether the inhibition of these pathways restored the invasive and migrative activity of these cells. As expected, treatment of HT1080 cells with PD98059 and mithramycin, but not SB202190 and SP600125, ameliorated the TGF-h1-mediated suppression of HT1080 cell invasion (Fig. 6A and B) and migration ( Fig. 6D and E) . However, treatment of the cells with curcumin together with TGF-h1 more suppressed the invasion (Fig. 6C) and migration (Fig. 6F ) of HT1080 cells. These additional inhibitory effects of HT1080 cell invasion and migration by curcumin were not due to cytotoxicity, because curcumin up to 10 Amol/L did not show any toxic effect on HT1080 cells in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (Supplementary Fig.  S3A ). In addition, flow cytometric analysis revealed no increase in the proportion of Annexin V -positive cells and propidium iodide -positive cells with up to 10 Amol/L curcumin ( Supplementary Fig. S3B ). However, significant cytotoxicity was detected with >35 Amol/L concentration of curcumin ( Supplementary Fig. S3B ). Therefore, these data strongly indicate that ERK1/2 and Sp1 signaling pathways are important for the induction of TIMP-1 and suppression of invasion of HT1080 cells by TGF-h1.
Discussion
Invasion of tumor cells through ECM and basement membrane barriers is a crucial step in tumor dissemination and metastasis (47, 48) . Proteolysis of ECM results from an imbalance between activators and inhibitors of proteinases, which are controlled by various cytokines or growth factors, including TGF-h1. Tumor cell invasion and migration activities are greatly increased by TGF-h1, leading to a more malignant phenotype (31, 34) . On the other hand, several studies showed that TGF-h1 is a potent growth suppressor of different normal and tumor cell types (27, 32) . Induction of TIMP-1 and inhibition of tumor cells invasion by TGF-h1 have been described previously in an invasive tumor cell line HT1080 (37); however, the regulation of these events by TGF-h1 has not been investigated. In the present study, therefore, we attempted to identify TGF-h1-induced signaling pathway that is involved in the regulation of TIMP-1 expression and invasion and migration by HT1080 cells and showed that TGF-h1 suppressed the invasion and migration of HT1080 cells by modulating the balance of ECM-degrading proteases and their inhibitor proteins. Specifically, TGF-h1 up-regulated MMP-2, MMP-9, and TIMP-1 expression, and augmentation of TIMP-1 by TGF-h1 might be responsible for suppressing invasion and migration of these cells. TGF-h1 induced TIMP-1 at both mRNA and protein levels in a dose-dependent manner. Furthermore, TGF-h1-induced TIMP-1 expression and antiinvasion and antimigration were regulated through the ERK1/ 2 signaling pathway and Sp1 transcription factor, suggesting the possible mechanism of anti-invasive and antimigrative action of TGF-h1 in HT1080 cells.
Invasion of tumor cells is determined by the net activity of ECM-degrading proteases and their inhibitors. Several reports showed that TGF-h1 stimulates tumor invasion by up-regulating integrin, MMP-2, MMP-9, and urokinase-type plasminogen activator expression (29) (30) (31) (32) (33) , while suppresses it by down-regulating plasminogen activator systems, MMPs, and plasmin-dependent ECM degradation through stimulating the expression of TIMP-1 and plasminogen activator inhibitor-1 (34-37). TGF-h1 suppression of invasion of HT1080 human fibrosarcoma cells seems to be largely due to the induction of TIMP-1 expression (9, 37). Consistent with the results of Kubota et al. (37) , our data also showed that TGF-h1 upregulated the expression and secretion of MMP-2, MMP-9, and TIMP-1 but not MT1-MMP and TIMP-2. Although TGF-h1 induced the expression of MMP-2 and MMP-9, the net invasive and migrative activity of HT1080 cells was down-regulated due to the induction of TIMP-1 by TGF-h1. Indeed, the addition of recombinant TIMP-1 reduced the invasion and migration of these cells. In other tumor cell systems, it has also been reported that reconstitution of Smad3 restores the TGF-h1-induced TIMP-1 expression and results in inhibiting the invasion of human choriocarcinoma cells (35) . On the contrary, TGF-h1 inhibited invasiveness of normal trophoblast by up-regulating the TIMP-1 level, but not in JAR and JEG-2 choriocarcinoma cells, which show very low level of TIMP-1 expression (49). Therefore, TIMP-1 induction by TGF-h1 is an important mechanism for inhibiting invasion of choriocarcinoma, at least in part. In addition, human hepatoma cells (HepG2) also produce TIMP-1 in response to TGF-h1 (50) . Therefore, TGFh1-induced TIMP-1 production might be critical mechanism for the suppression of invasion in some tumor cells, such as fibrosarcoma, choriocarcinoma, and hepatoma, although further studies are needed to uncover the critical role of TIMP-1 in invasiveness of these tumors.
Several external stimuli, such as growth factors, phorbol esters, and cytokines, induce TIMP-1 expression in various cell types (9) . However, the regulation mechanism of TIMP-1 is not well understood. Tong et al. reported that ERK1/2 and p38 pathways are required for maximal regulation of TIMP-1 in murine fibroblast by oncostatin M (24), and Kadri et al. showed that erythropoietin-induced TIMP-1 expression and secretion are mediated by ERK1/2 and PI3K/Akt signaling pathway (25) . In line with these studies, we also examined the involvement of MAPK and PI3K/Akt pathways in the regulation of TIMP-1 by TGF-h1 in HT1080 cells. TGF-h1 phosphorylated three MAPKs (ERK1/2, p38, and JNK) and Akt, a PI3K downstream effector molecule. By using specific kinase inhibitors of these kinases, we found that the activation of ERK1/2 pathway was involved in TGF-h1-induced TIMP-1 expression and secretion in HT1080 cells. Actually, PD98059, a specific inhibitor of MEK, which is upstream kinase of ERK1/2, but not SB202190, SP600125, and LY294002, specific inhibitors of p38, JNK, and PI3K, respectively, could effectively inhibit TIMP-1 expression and secretion induced by TGF-h1 in these cells. Furthermore, transient transfection of DN-MEK-1, but not DN-p38 and DN-JNK, abrogated the induction of TIMP-1 by TGF-h1. To our best knowledge, this is the first report to show that induction of TIMP-1 by TGF-h1 is regulated by ERK1/2 signaling pathway. In addition, Matrigel invasion and Transwell migration assays showed that blockade of ERK1/2 pathway by PD98059 restored the invasion and migration of HT1080 cells from the invasion and migration suppressive effect of TGF-h1. Therefore, in HT1080 cells, ERK1/2 pathway plays an important role in TIMP-1 expression following the suppression of invasion and migration by TGF-h1.
Regulation of TIMP-1 gene expression is mainly mediated at the transcription level and involves the activation of several well-known transcription factors, including those belonging to AP-1, Sp1, and Pea3/Ets families (45) . A recent report shows that the up-regulation of TIMP-1 promoter activity by TGFh1 requires the AP-1 response element (51) . In other stimulatory systems, such as oncostatin M and erythropoietin, the dependence of TIMP-1 expression on AP-1 has also been described (25, 49) . In the present study, we examined which transcription factor was related with the expression of TIMP-1 and found that mithramycin, a specific Sp1 inhibitor, but not curcumin, which is known as an AP-1 inhibitor, significantly inhibited TGF-h1-induced TIMP-1 expression. In addition, transfection of siRNA for Sp1 dramatically diminished the TIMP-1 expression, and TGF-h1 increased the Sp1 DNA-binding activity and PD98059 and mithramycin effectively suppressed this increase. The inhibitory effect of PD98059 on Sp1 DNA-binding activity implies that the ERK1/2 signal pathway is critical for TGF-h1-induced Sp1 activation and TIMP-1 expression. We cannot, however, rule out the possible involvement of AP-1, the well-known transcription factor for TIMP-1 expression (25, 51, 52) , and other transcription factors. Nevertheless, it is certain that Sp1 transcription factor is dominantly involved in the induction of TIMP-1 by TGF-h1 in these cell systems, partly at least. Therefore, the above observations led us to conclude that TGF-h1 increases TIMP-1 expression through ERK1/2 and Sp1 signaling pathways. In summary, the data described above showed that TGF-h1 inhibited pericellular proteolysis by inducing the expression of TIMP-1 in HT1080 cells. Mechanistic analyses showed that ERK1/2 activation of TGF-h1 regulated the levels of TIMP-1 expression and this regulation was largely mediated by the regulation of transcription factor, Sp1. These results provide important clues in the regulatory mechanisms underlying TGF-h1-induced inhibition of tumor cell invasion and migration.
Materials and Methods
Reagents and Cell Culture
Recombinant human TGF-h1 was purchased from Biosource Co. (Camarillo, CA). Antibodies against MT1-MMP, MMP-2, MMP-9, TIMP-1, and TIMP-2 were obtained from Calbiochem (La Jolla, CA), and antibodies against phosphorylated ERK1/2, p38, JNK, and Akt were from New England Biolabs (Beverly, MA). The following kinase inhibitors were purchased from Calbiochem and used in this study: PD98059 (ERK1/2), SB202190 (p38), SP600125 (JNK), and LY294002 (PI3K). Matrigel was purchased from Becton Dickinson (Bedford, MA), and gelatin and type I collagen were purchased from Sigma Chemical Co. (St. Louis, MO). HT1080 cells were grown in DMEM (Life Technologies, Grand Island, NY) supplemented with 2 mmol/L glutamine, 1 mmol/L sodium pyruvate, 100 units/mL penicillin, 100 Ag/mL streptomycin (Life Technologies), and 10% heat-inactivated fetal bovine serum (Life Technologies) in a humidified incubator containing 5% CO 2 at 37jC. confluence in DMEM containing 10% fetal bovine serum, and medium was changed to serum-free medium. Cells were stimulated with TGF-h1 (10 ng/mL) in the presence or absence of MEK inhibitor, PD98059, mithramycin, or curcumin for 4 hours. Nuclear extracts from the cells were subjected to gel shift assay with Sp1 (A) and AP-1 (B) consensus oligonucleotides as described in Materials and Methods. For the detection of Sp1 supershift band, nuclear extracts from TGF-h1-treated cells were incubated with anti-Sp1 antibody for 30 minutes on ice and analyzed by electrophoretic mobility shift assay. Negative control, 32 
Transfection and Transduction
DN-MEK-1 plasmids (generous gift from Dr. Su-Jae Lee, Korea Institute of Radiological and Medical Sciences, Seoul, Korea) were transfected in HT1080 cells, using Effectene transfection reagent (Qiagen, Valencia, CA), by following the supplier's instructions. For retrovirus transduction, cells were infected with retrovirus harboring DN-p38 and DN-JNK-1 (generous gift from Dr. Su-Jae Lee) for 90 minutes. After 24 hours, transfected and transduced cells were washed twice with serum-free medium and incubated with or without TGFh1 (10 ng/mL) in the same medium. The infection and selection of the target cells by puromycin were done as described previously (51) . The siRNA against Sp1 and TIMP-1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and transfections of cells with siRNA molecules were done using RNAiFect transfection reagent (Qiagen) as described by the manufacturer.
Zymography
Production of MMPs by HT1080 cells was analyzed by gelatin zymography. HT1080 cells in subconfluent culture condition (f70-80% confluent) were washed and replenished with serum-free DMEM and incubated with or without indicated concentrations of TGF-h1 in the presence or absence of various kinase inhibitors for 18 hours. Serum-free conditioned medium (20 AL) was mixed with SDS sample buffer without heating or reduction and applied to 10% polyacrylamide gels copolymerized with 1 mg/mL gelatin. After electrophoresis, gels were washed in 2.5% (v/v) Triton X-100 for 2 hours at room temperature to remove SDS, rinsed twice with water, and then incubated in developing buffer [50 mmol/ L Tris-HCl (pH 7.5), 5 mmol/L CaCl 2 , 1 Amol/L ZnCl 2 , and 0.1 NaN 3 ] for 18 hours at 37jC.
Subsequently, gels were fixed and stained with 10% 2-propanol and 10% acetic acid containing 0.5% Coomassie blue R250. The protease activity was visualized as clear bands within the stained gel.
Invasion and Migration Assays
Matrigel invasion assays were done using modified Boyden chambers with polycarbonate Nucleopore membrane (Corning, Corning, NY). Precoated filters (6.5 mm in diameter, 8-Am pore size, Matrigel 100 Ag/cm 2 ) were rehydrated with 100 AL medium. Then, 2 Â 10 5 cells in 200 AL serum-free DMEM supplemented with 0.1% bovine serum albumin were seeded into the upper part of each chamber, whereas the lower compartments were filled with 1 mL of the same medium mentioned above in the presence or absence of TGF-h1 (10 ng/mL) with or without specific kinase inhibitors or TIMP-1. Following incubation for 18 hours at 37jC, noninvaded cells on the upper surface of the filter were wiped out with a cotton swab, and the invaded cells on the lower surface of the filter were fixed and stained with Diff-Quick kit (Fisher Scientific, Pittsburgh, PA). Invasiveness was determined by counting cells in five microscopic fields per well, and the extent of invasion was expressed as an average number of cells per microscopic field. Transwell migration assays were done using the same procedure as for invasion assay, except coating the underside of filters with type I collagen (100 Ag/cm 2 ).
Western Blot Analysis HT1080 cells were lysed in lysis buffer [20 mmol/L TrisHCl (pH 7.4), 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1% Triton X-100, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L h-glycerophosphate, 1 mmol/L Na 3 VO 4 , 1 Ag/mL leupeptin, and 1 mmol/L phenylmethylsulfonyl fluoride]. After a brief sonication, the lysates were clarified by centrifugation at 12,000 Â g for 10 minutes at 4jC, and protein content in the supernatant was measured by the Bradford method. An aliquot (30-50 Ag protein/lane) of the total protein was separated by 10% or 12% SDS-PAGE and blotted to nitrocellulose transfer membrane (0.2 Am; Amersham, Arlington Heights, IL). The membrane was blocked with 5% nonfat skim milk in TBST [20 mmol/L Tris-HCl (pH 7.6), 137 mmol/L NaCl, and 0.01% Tween 20] for 1 hour at room temperature followed by incubation with the primary antibodies. After extensive washing with TBST, the membrane was reprobed with horseradish peroxidase -linked anti-rabbit immunoglobulin, at 1:3,000 diluted in 5% nonfat skim milk in TBST, for 40 minutes at room temperature. Immunoblots were visualized by enhanced chemiluminescence (Amersham) according to the manufacturer's protocol.
To measure the MMP-2, MMP-9, TIMP-1, and TIMP-2 proteins secreted, the conditioned medium from each sample was also subjected to protein analysis. For this purpose, culture medium in each tissue culture dish was collected and concentrated 10-fold using a Centricon 10 microconcentrator (Amicon, Beverly, MA). The concentrates were subjected to SDS-PAGE analysis.
Real-time PCR
Real-time PCR assays were done using QuantiTect SYBER Green PCR kit (Qiagen) with SYBR Green I as the fluorescent dye enabling real-time detection of PCR products according to the manufacturer's protocol. Gene-specific primers were used, and the specificity was tested under normal PCR conditions. Oligonucleotide primer sequences were as follows: human TIMP-1 sense (5V -ACCAGACCACCTTATACCAGCG-3V ) and antisense (5V -GGACTGGAAGCCCTTTTCAGAG-3V ), human MMP-2 sense (5V -GAGAACCAAAGTCTGAAGAG-3V ) and antisense (5V -GGAGTGAGAATGCTGATTAG-3V ), and human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sense (5V -TGAACGGGAAGCTCACTGG-3V ) and antisense (5V -TCCACCACCCTGTTGCTGTA-3V ). Cycling conditions were 95jC for 15 minutes followed by 35 cycles of 94jC for 15 seconds, 60jC for 30 seconds, and 72jC for 30 seconds. For quantification, the target gene was normalized to the internal standard GAPDH gene. Results of the real-time PCR data were represented as Ct values, where Ct is defined as the threshold cycle of PCR at which amplified product was first detected. To compare the different RNA samples in an experiment, we used the comparative Ct method (53) and compared the RNA expression in samples with that of the control in each experiment. The primers were constructed so that the dynamic range of both the targets and the GAPDH reference were similar over a wide range of dilutions (1:1-10,000). PCR was done in triplicates for each sample. The results were expressed as mean F SD for the relative expression levels compared with the control, and minimum values of three independent experiments were taken.
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide Assays
A tetrazolium-based assay was used to determine the cytotoxicity. Briefly, 2,000 cells were seeded in 96-well plates and cultured for 24 hours, and seven concentrations of TGF-h1 or curcumin were added, respectively. Cell viability was examined at 12 and 24 hours after treatment. Before testing, 10 AL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide labeling reagent (5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in PBS) was added and the cells were incubated for 4 hours at 37jC. Then, 100 AL dissolving reagent (DMSO) was added and the plate was further incubated for 15 minutes at 37jC to dissolve the formazan crystals. The absorbance was measured at a wavelength of 570 nm on a Labsystem multiscan microplate reader (Merck Eurolab, Dietikon, Switzerland). Results represented the absorbance ratio between treated and untreated cells at indicated time points. Results are expressed as mean F SD.
Evaluation of Apoptosis
Apoptosis was evaluated by staining the cells with Annexin V-FITC (PharMingen, San Diego, CA) and propidium iodide according to the manufacturer's protocol. Cells were then analyzed by FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ).
Electrophoretic Mobility Gel Shift Assay
Electrophoretic mobility shift assay was done as described elsewhere (54) with some modifications. Nuclear extracts were prepared from HT1080 cells treated with or without TGF-h1 (10 ng/mL) and specific kinase inhibitors. Synthetic oligonucleotides consisting of consensus sequences of Sp1 (5V -ATTCG-ATCGGGGCGGGGCGAGC-3V ) and AP-1 (5V -CGCTTGA-TGACTCAGCCGGAA-3V ; Santa Cruz Biotechnology) were used as probes after annealing sense and antisense fragments. The double-stranded oligonucleotides were then labeled with [g-32 P]ATP. Nuclear extracts (10 Ag) were incubated with 5 Â 10 4 counts/min labeled probes for 30 minutes at 22jC and analyzed in 6% PAGE followed by autoradiography. For supershift analysis, nuclear extracts were preincubated with Sp1 antibody (2 or 4 Ag) on ice for 30 minutes before the addition of labeled double-stranded oligonucleotides followed by incubation at room temperature for an additional 20 minutes.
Statistical Analysis
All results are mean F SD or SE. Statistical significance was determined using Student's t test.
